Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
10,984.40
9,839.00
8,748.20
7,604.40
6,209.40
4,130.27
3,048.85
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
10,984.40
9,839.00
8,748.20
7,604.40
6,209.40
4,130.27
3,048.85
Raw Material Cost
1,530.50
1,262.20
1,080.30
904.20
736.30
547.76
409.54
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
30.60
44.10
54.80
61.50
58.15
58.50
34.12
Selling and Distribution Expenses
1,464.30
1,136.60
944.70
840.10
770.46
658.50
557.62
Other Expenses
359.97
311.88
258.80
298.96
177.14
169.60
138.24
Total Expenditure (Excl Depreciation)
6,625.10
5,561.70
4,667.80
4,795.40
3,336.29
2,960.80
2,383.63
Operating Profit (PBDIT) excl Other Income
4359.3
4277.3
4080.4
2809
2873.1
1169.5
665.1999999999999
Other Income
545.50
625.20
321.30
-18.70
156.66
160.74
-2.67
Operating Profit (PBDIT)
5,110.60
5,083.80
4,550.00
2,915.90
3,139.28
1,437.16
734.97
Interest
30.60
44.10
54.80
61.50
58.15
58.50
34.12
Exceptional Items
-4,625.70
-478.60
-114.50
1.60
145.18
123.20
-28.19
Gross Profit (PBDT)
9,453.90
8,576.80
7,667.90
6,700.20
5,473.10
3,582.52
2,639.31
Depreciation
205.80
181.30
148.30
125.60
109.52
106.94
72.42
Profit Before Tax
248.50
4,379.80
4,232.40
2,730.40
3,116.80
1,394.92
600.24
Tax
784.10
760.20
910.40
388.30
405.15
218.11
-1,486.86
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
-535.60
3,619.60
3,322.00
2,342.10
2,711.65
1,176.81
2,096.39
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
-535.60
3,619.60
3,322.00
2,342.10
2,711.65
1,176.81
2,096.39
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
-9.79
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
-535.60
3,619.60
3,322.00
2,342.10
2,711.65
1,176.81
2,086.60
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.01
0.01
0.01
0.01
0.01
0.01
0.01
Reserves
16,409.60
17,580.40
13,912.70
10,100.00
8,686.82
6,085.24
4,435.20
Earnings per share (EPS)
-2.08
13.89
12.82
9.01
10.29
4.51
8.09
Diluted Earnings per share
-2.08
13.89
12.82
9.01
10.29
4.51
8.09
Operating Profit Margin (Excl OI)
39.69%
43.47%
46.64%
36.94%
46.27%
28.31%
21.82%
Gross Profit Margin
4.14%
46.36%
50.08%
37.56%
51.96%
36.36%
22.06%
PAT Margin
-4.88%
36.79%
37.97%
30.8%
43.67%
28.49%
68.76%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2024 is 11.64% vs 12.47% in Dec 2023
Consolidate Net Profit
YoY Growth in year ended Dec 2024 is -114.80% vs 8.96% in Dec 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2024 is 2.39% vs 5.44% in Dec 2023
Interest
YoY Growth in year ended Dec 2024 is -30.61% vs -19.53% in Dec 2023
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2024 has fallen from Dec 2023
Compare Annual Results Of Vertex Pharmaceuticals, Inc. With
Figures in Million
Consolidate Annual Results
Change(USD)
Change(%)
Net Sales
10,984.40
48,300.00
-37,315.60
-77.26%
Other Operating Income
0.00
0.00
0.00
Total Operating income
10,984.40
48,300.00
-37,315.60
-77.26%
Raw Material Cost
1,530.50
20,868.00
-19,337.50
-92.67%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
30.60
1,947.00
-1,916.40
-98.43%
Selling and Distribution Expenses
1,464.30
7,992.00
-6,527.70
-81.68%
Other Expenses
359.97
783.50
-423.53
-54.06%
Total Expenditure (Excl Depreciation)
6,625.10
38,642.00
-32,016.90
-82.86%
Operating Profit (PBDIT) excl Other Income
4,359.30
9,658.00
-5,298.70
-54.86%
Other Income
545.50
2,064.00
-1,518.50
-73.57%
Operating Profit (PBDIT)
5,110.60
21,373.00
-16,262.40
-76.09%
Interest
30.60
1,947.00
-1,916.40
-98.43%
Exceptional Items
-4,625.70
-18,154.00
13,528.30
74.52%
Gross Profit (PBDT)
9,453.90
27,432.00
-17,978.10
-65.54%
Depreciation
205.80
9,651.00
-9,445.20
-97.87%
Profit Before Tax
248.50
-8,379.00
8,627.50
102.97%
Tax
784.10
554.00
230.10
41.53%
Provisions and contingencies
0
0
0.00
Profit After Tax
-535.60
-8,948.00
8,412.40
94.01%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
-535.60
-8,948.00
8,412.40
94.01%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
15.00
-15.00
-100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
-535.60
-8,933.00
8,397.40
94.00%
Equity Capital
0
0
0.00
Face Value
0.01
0.10
0.00
Reserves
16,409.60
16,335.00
74.60
0.46%
Earnings per share (EPS)
-2.08
-4.41
2.33
52.83%
Diluted Earnings per share
-2.08
-4.41
2.33
52.83%
Operating Profit Margin (Excl OI)
39.69%
20.00%
0.00
19.69%
Gross Profit Margin
4.14%
2.63%
0.00
1.51%
PAT Margin
-4.88%
-18.53%
0.00
13.65%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 1,098.44 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 11.64% vs 12.47% in Dec 2023
Annual - Consolidate Net Profit
Consolidate Net Profit -53.56 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is -114.80% vs 8.96% in Dec 2023
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 456.51 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 2.39% vs 5.44% in Dec 2023
Annual - Interest
Interest 3.06 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is -30.61% vs -19.53% in Dec 2023
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 39.69%
in Dec 2024Figures in %
YoY Growth in year ended Dec 2024 has fallen from Dec 2023






